PYRAZOLOPYRIMIDINE DERIVATIVES

The present invention covers Pyrazolopyrimidine compounds of general formula (I), in which n, o, X, Y, R, Q, R1, R2, R3 and R4 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprisi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SCHWARZ, HANS-GEORG, HINK, MAIKE, GORGENS, ULRICH, BORNGEN, KIRSTEN, EBBINGHAUS-KINTSCHER, ULRICH, BOHM, CLAUDIA, KOBBERLING, JOHANNES, ILG, THOMAS, HUBSCH, WALTER, NENNSTIEL, DIRK, ADAMCZEWSKI, MARTIN, GRIEBENOW, NILS, WELZ, CLAUDIA, KULKE, DANIEL, KOHLER, ADELINE, ZHUANG, WEI, RAMING, KLAUS
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention covers Pyrazolopyrimidine compounds of general formula (I), in which n, o, X, Y, R, Q, R1, R2, R3 and R4 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients. La présente invention concerne des composés pyrazolopyrimidiniques de formule générale (I), dans laquelle n, o, X, Y, R, Q, R1, R2, R3 et R4 sont tels que définis dans la description, des procédés de préparation desdits composés, des composés intermédiaires utiles pour préparer lesdits composés, des compositions et des combinaisons pharmaceutiques comprenant lesdits composés et l'utilisation desdits composés pour fabriquer des compositions pharmaceutiques pour le traitement ou la prévention de maladies, en particulier de maladies infection helminthiques, en monothérapie ou en association avec d'autres principes actifs.